Background: Inflammation of peripheral airways is implicated in the pathophysiology of severe asthma. However, contributions of peripheral airway inflammation to airway caliber/function in patients with stable asthma, including those with mild to moderate disease, remain to be confirmed. Objectives: To determine whether peripheral airway inflammation affects airway function in patients with asthma. Methods: In 70 patients with mild to severe asthma, alveolar nitric oxide [CANO(TMAD)] levels were examined as a noninvasive biomarker of peripheral airway/alveolar inflammation. CANO(TMAD) and maximal nitric oxide (NO) flux in the airway compartment, J’awNO, were estimated with a model that incorporated trumpet-shaped airways and axial diffusion using exhaled NO output at different flow rates. Measures of pulmonary function were then assessed by spirometry and an impulse oscillometry system, and their bronchodilator reversibility was examined. Results: CANO(TMAD) levels were not correlated with pre- or postbronchodilator spirometric values, but were significantly associated with prebronchodilator reactance at low frequency (Xrs5) (rho = –0.31, p = 0.011), integrated area of low-frequency Xrs (AX) (rho = 0.35, p = 0.003) and negative frequency dependence of resistance (Rrs5-Rrs20) (rho = 0.35, p = 0.004). Furthermore, CANO(TMAD) levels were associated with bronchodilator reversibility of FEV1, FEF25–75%, Xrs5 and AX (rho = 0.35, 0.31, –0.24 and –0.31, respectively; p ≤ 0.05 for all). No variables were related to J’awNO. Conclusions: Elevated CANO(TMAD), but not J’awNO, partly reflects reversible airway obstruction originating in the peripheral airway. These findings indicate the involvement of peripheral airway inflammation in physiological abnormalities in asthma.

1.
Carroll N, Cooke C, James A: The distribution of eosinophils and lymphocytes in the large and small airways of asthmatics. Eur Respir J 1997;10:292–300.
2.
Hamid Q, Song Y, Kotsimbos TC, Minshall E, Bai TR, Hegele RG, Hogg JC: Inflammation of small airways in asthma. J Allergy Clin Immunol 1997;100:44–51.
3.
Kraft M: The distal airways: are they important in asthma? Eur Respir J 1999;14:1403–1417.
4.
Verbanck S, Schuermans D, Noppen M, Van Muylem A, Paiva M, Vincken W: Evidence of acinar airway involvement in asthma. Am J Respir Crit Care Med 1999;159:1545–1550.
5.
Silkoff PE, Erzurum SC, Lundberg JO, George SC, Marczin N, Hunt JF, Effros R, Horvath I, American Thoracic Society, HOC Subcommittee of the Assembly on Allergy, Immunology, and Inflammation: ATS workshop proceedings: Exhaled nitric oxide and nitric oxide oxidative metabolism in exhaled breath condensate. Proc Am Thorac Soc 2006;3:131–145.
6.
Tsoukias NM, George SC: A two-compartment model of pulmonary nitric oxide exchange dynamics. J Appl Physiol 1998;85:653–666.
7.
Gelb AF, Taylor CF, Nussbaum E, Gutierrez C, Schein A, Shinar CM, Schein MJ, Epstein JD, Zamel N: Alveolar and airway sites of nitric oxide inflammation in treated asthma. Am J Respir Crit Care Med 2004;170:737–741.
8.
Paraskakis E, Brindicci C, Fleming L, Krol R, Kharitonov SA, Wilson NM, Barnes PJ, Bush A: Measurement of bronchial and alveolar nitric oxide production in normal children and children with asthma. Am J Respir Crit Care Med 2006;174:260–267.
9.
Berry M, Hargadon B, Morgan A, Shelley M, Richter J, Shaw D, Green RH, Brightling C, Wardlaw AJ, Pavord ID: Alveolar nitric oxide in adults with asthma: Evidence of distal lung inflammation in refractory asthma. Eur Respir J 2005;25:986–991.
10.
Condorelli P, Shin HW, Aledia AS, Silkoff PE, George SC: A simple technique to characterize proximal and peripheral nitric oxide exchange using constant flow exhalations and an axial diffusion model. J Appl Physiol 2007;102:417–425.
11.
Kerckx Y, Michils A, Van Muylem A: Airway contribution to alveolar nitric oxide in healthy subjects and stable asthma patients. J Appl Physiol 2008;104:918–924.
12.
in ‘t Veen JC, Beekman AJ, Bel EH, Sterk PJ: Recurrent exacerbations in severe asthma are associated with enhanced airway closure during stable episodes. Am J Respir Crit Care Med 2000;161:1902–1906.
13.
Ueda T, Niimi A, Matsumoto H, Takemura M, Hirai T, Yamaguchi M, Matsuoka H, Jinnai M, Muro S, Chin K, Mishima M: Role of small airways in asthma: Investigation using high-resolution computed tomography. J Allergy Clin Immunol 2006;118:1019–1025.
14.
van Veen IH, Sterk PJ, Schot R, Gauw SA, Rabe KF, Bel EH: Alveolar nitric oxide versus measures of peripheral airway dysfunction in severe asthma. Eur Respir J 2006;27:951–956.
15.
Mahut B, Delclaux C, Tillie-Leblond I, Gosset P, Delacourt C, Zerah-Lancner F, Harf A, de Blic J: Both inflammation and remodeling influence nitric oxide output in children with refractory asthma. J Allergy Clin Immunol 2004;113:252–256.
16.
Goldman MD, Saadeh C, Ross D: Clinical applications of forced oscillation to assess peripheral airway function. Respir Physiol Neurobiol 2005;148:179–194.
17.
Smith HJ, Reinhold P, Goldman MD: Forced oscillation technique and impulse oscillometry. Eur Respir Mon 2005;31:72–105.
18.
Standards for the diagnosis and care of patients with chronic obstructive pulmonary disease (COPD) and asthma. This official statement of the American Thoracic Society was adopted by the ATS board of directors, November 1986. Am Rev Respir Dis 1987;136:225–244.
19.
Global strategy for asthma management and prevention. Publication No. 02-3659. Bethesda, National Institute of Health/National Heart, Lung, and Blood Institute, 2004.
20.
ATS/ERS recommendations for standardized procedures for the online and offline measurement of exhaled lower respiratory nitric oxide and nasal nitric oxide, 2005. Am J Respir Crit Care Med 2005;171:912–930.
21.
Standardization of spirometry, 1994 update. American Thoracic Society. Am J Respir Crit Care Med 1995;152:1107–1136.
22.
Oostveen E, MacLeod D, Lorino H, Farre R, Hantos Z, Desager K, Marchal F: The forced oscillation technique in clinical practice: methodology, recommendations and future developments. Eur Respir J 2003;22:1026–1041.
23.
Balzar S, Wenzel SE, Chu HW: Transbronchial biopsy as a tool to evaluate small airways in asthma. Eur Respir J 2002;20:254–259.
24.
Wenzel S: Severe asthma in adults. Am J Respir Crit Care Med 2005;172:149–160.
25.
Brindicci C, Ito K, Barnes PJ, Kharitonov SA: Differential flow analysis of exhaled nitric oxide in patients with asthma of differing severity. Chest 2007;131:1353–1362.
26.
Mahut B, Trinquart L, Le Bourgeois M, Becquemin MH, Beydon N, Aubourg F, Jala M, Bidaud-Chevalier B, Dinh-Xuan AT, Randrianarivelo O, Denjean A, de Blic J, Delclaux C: Multicentre trial evaluating alveolar no fraction as a marker of asthma control and severity. Allergy 2010;65:636–644.
27.
Larsen GL, Morgan W, Heldt GP, Mauger DT, Boehmer SJ, Chinchilli VM, Lemanske RF, Jr., Martinez F, Strunk RC, Szefler SJ, Zeiger RS, Taussig LM, Bacharier LB, Guilbert TW, Radford S, Sorkness CA: Impulse oscillometry versus spirometry in a long-term study of controller therapy for pediatric asthma. J Allergy Clin Immunol 2008;123:861–867.
28.
Takeda T, Oga T, Niimi A, Matsumoto H, Ito I, Yamaguchi M, Matsuoka H, Jinnai M, Otsuka K, Oguma T, Nakaji H, Chin K, Mishima M: Relationship between small airway function and health status, dyspnea and disease control in asthma. Respiration 2010;80:120–126.
29.
Clement J, Landser FJ, Van de Woestijne KP: Total resistance and reactance in patients with respiratory complaints with and without airways obstruction. Chest 1983;83:215–220.
30.
Kolsum U, Borrill Z, Roy K, Starkey C, Vestbo J, Houghton C, Singh D: Impulse oscillometry in COPD: Identification of measurements related to airway obstruction, airway conductance and lung volumes. Respir Med 2008.
31.
Kraft M, Djukanovic R, Wilson S, Holgate ST, Martin RJ: Alveolar tissue inflammation in asthma. Am J Respir Crit Care Med 1996;154:1505–1510.
32.
Colon-Semidey AJ, Marshik P, Crowley M, Katz R, Kelly HW: Correlation between reversibility of airway obstruction and exhaled nitric oxide levels in children with stable bronchial asthma. Pediatr Pulmonol 2000;30:385–392.
33.
Silvestri M, Sabatini F, Sale R, Defilippi AC, Fregonese L, Battistini E, Biraghi MG, Rossi GA: Correlations between exhaled nitric oxide levels, blood eosinophilia, and airway obstruction reversibility in childhood asthma are detectable only in atopic individuals. Pediatr Pulmonol 2003;35:358–363.
34.
Puckett JL, Taylor RW, Leu SY, Guijon OL, Aledia AS, Galant SP, George SC: An elevated bronchodilator response predicts large airway inflammation in mild asthma. Pediatr Pulmonol 2010;45:174–181.
35.
Tsuburai T, Tsurikisawa N, Taniguchi M, Morita S, Ono E, Oshikata C, Ohtomo M, Maeda Y, Ikehara K, Akiyama K: The relationship between exhaled nitric oxide measured with an off-line method and airway reversible obstruction in Japanese adults with asthma. Allergol Int 2007;56:37–43.
36.
Shin HW, Rose-Gottron CM, Cooper DM, Newcomb RL, George SC: Airway diffusing capacity of nitric oxide and steroid therapy in asthma. J Appl Physiol 2004;96:65–75.
37.
Lehtimaki L, Kankaanranta H, Saarelainen S, Turjanmaa V, Moilanen E: Inhaled fluticasone decreases bronchial but not alveolar nitric oxide output in asthma. Eur Respir J 2001;18:635–639.
38.
Dupont LJ, Rochette F, Demedts MG, Verleden GM: Exhaled nitric oxide correlates with airway hyperresponsiveness in steroid-naive patients with mild asthma. Am J Respir Crit Care Med 1998;157:894–898.
39.
Tsujino I, Nishimura M, Kamachi A, Makita H, Munakata M, Miyamoto K, Kawakami Y: Exhaled nitric oxide – is it really a good marker of airway inflammation in bronchial asthma? Respiration 2000;67:645–651.
40.
Mahut B, Trinquart L, Bokov P, Peiffer C, Delclaux C: The link between exhaled no and bronchomotor tone depends on the dose of inhaled steroid in asthma. Respir Med 2010;104:945–950.
41.
Kaczka DW, Ingenito EP, Suki B, Lutchen KR: Partitioning airway and lung tissue resistances in humans: effects of bronchoconstriction. J Appl Physiol 1997;82:1531–1541.
42.
Puckett JL, Taylor RW, Leu SY, Guijon OL, Aledia AS, Galant SP, George SC: Clinical patterns in asthma based on proximal and distal airway nitric oxide categories. Respir Res 2010;11:47.
Copyright / Drug Dosage / Disclaimer
Copyright: All rights reserved. No part of this publication may be translated into other languages, reproduced or utilized in any form or by any means, electronic or mechanical, including photocopying, recording, microcopying, or by any information storage and retrieval system, without permission in writing from the publisher.
Drug Dosage: The authors and the publisher have exerted every effort to ensure that drug selection and dosage set forth in this text are in accord with current recommendations and practice at the time of publication. However, in view of ongoing research, changes in government regulations, and the constant flow of information relating to drug therapy and drug reactions, the reader is urged to check the package insert for each drug for any changes in indications and dosage and for added warnings and precautions. This is particularly important when the recommended agent is a new and/or infrequently employed drug.
Disclaimer: The statements, opinions and data contained in this publication are solely those of the individual authors and contributors and not of the publishers and the editor(s). The appearance of advertisements or/and product references in the publication is not a warranty, endorsement, or approval of the products or services advertised or of their effectiveness, quality or safety. The publisher and the editor(s) disclaim responsibility for any injury to persons or property resulting from any ideas, methods, instructions or products referred to in the content or advertisements.
You do not currently have access to this content.